Abstract
Introduction 1
Enniatins (ENs) are secondary fungal metabolites that have been known for several decades 2 (Ivanova et al., 2006) . Chemically there are six-membered cyclic depsipeptides, which are 3 commonly composed of three D-α-hydroxyisovaleric acid (Hiv) residues linked 4 alternatively to three L-configured N-methyl amino acid residues to give an 18-membered 5 cyclic skeleton (Zhukhlistova et al., 1999) . ENs are produced by strains of several species et al., 2004; Ivanova et al., 2006; Jestoi, 2008; Lee et al., 2008; Behm et al., 2009; 1 Dornetshuber et al., 2009; Hyun et al., 2009; Watjen et al., 2009; Meca et al., 2010b Meca et al., , 2011 .
2
In the scientific literature, only few studies related to the ENs toxicity in vivo are available.
3
In particular, Bosch et al. (1989) studied the toxicity of ENs, among other mycotoxins, in 4 Fusarium contaminated feed on twenty day old white female Spargue Dawley rats, 5 evidencing no toxic signs. To be sure about which mycotoxins where responsible of the 6 effects, they administrated a mixture of ENNs in single oral dose (0.05 mg/g body weight
7
(bw)). McKee et al. (1997) studied a hypothetic ENs property to reduce the human 8 immunodeficiency virus (HIV) growth using the hollow fiber assay and employing mice as 9 biological model. They used an ENs A1, B and B1 purified mixture (from 1.25 to 40 10 mg/kg) injected intraperitoneally every 8h during 6 days. Any anti-HIV properties were not 11 found but 40, 20 and 10 mg/kg doses were lethal.
12
Considering the lack of information in physiological conditions related to the ENs toxicity 13 in vivo, the aims of this research were: a) to study the EN A in vivo potential toxicity trough were degassed for 20 min using a Branson 5200 ultrasonic bath (Branson Ultrasonic Corp., 1 CT, USA). Potato dextrose broth (PDB) was obtained from Insulab (Valencia, Spain).
2
Phosphate Buffered Saline (PBS), glycerol and ENs A standard solution stock (purity: 99% 3 molecular weight 682.92 g/mol) were purchased from Sigma Aldrich (Madrid, Spain). Vallés, Spain) was utilized in this study. The medium was prepared weighting 5 kg in two 7 2.5 L Erlenmeyer flasks and autoclaved at 121ºC during 20 min. Each one was inoculated 8 with 25 ml of a conidia suspension (10 6 conidia/ml sterile water) of Fusarium tricinctum
9
CECT 20232 in PDB. Conidial concentration was measured by optical density at 600 nm in 10 sterile water and adjusted to 10 6 conidia/ml PDB as reported Kelly et al. (2006 with 2 ml of ethyl acetate using a vortex VWR international (Barcelona, Spain) for 3 min.
4
Following steps were performed as described in section 2.6.
5
2.8 EN A extraction from tissues 6 EN A contained in the tissues collected from control and treated rats was extracted as 7 follows: 0.5 g of each tissue was introduced in a 15 ml plastic tube and 2 ml of PBS (1X, 8 pH 7.5) was added. Sample were completely grounded using an Ultraturrax T8 IKA
9
(Staufen, Germany) during 3 min. EN A was extracted from the PBS solution using 4 ml of 10 ethyl acetate employing a vortex (VWR international, Barcelona, Spain) during 3 min.
11
Following steps were performed as described in section 2.6. kept constant for 5 min and then it was linearly modified to 90% acetonitrile in 10 min.
18
After 1 min the mobile phase was set to the initial conditions in 4 min. permitted to obtain an enhanced characterization of the isolated compounds. 
Mass spectrometry characterization of the EN A degradation products

19
Characterization of the newly formed compounds was performed as explained in 2.10 using 20 the LC coupled to LIT in ER mode.
Calculations
1
Recoveries of fortified tissues and biological fluid samples were calculated as the 2 percentage of the EN A detected amount related to the total EN A spiked in each of them.
3
Recovery studies were performed in triplicate and the spiking levels were 1.0, 5.0 and 10 4 µg/g.
5
For the treated rats liquid contents and tissues, the absolute amount of mycotoxins (mg) 6 was calculated by multiplying the measured sample volume or weight by the EN A 7 concentration found. Mean recovery of fortified tissues and biological fluid samples (n = 3) at 3 levels of EN A
11
(1.0, 5.0 and 10 µg/g.), was of 97.8% (range= 70-156%) with a relative standard deviations 12 of 3.5% (range= 1.5-5.5%). Intra-day (n= 5) and inter-day (5 different days) precision were 13 2.4% and 9.0%, respectively. These values were below ±10% which is the maximum (Table 1) . This study was designed as a 28-day repeated dose assay in rats using the bioactive 7 compound EN A. Ten 2 months-old female Wistar rats were divided in two groups (treated 8 and control), five in each cage. During 28 days, the treated group was fed ad libitum with 9 the EN A contaminated feed whereas the control group was fed simultaneously with 10 standard feed.
Rats were observed and weighted weekly (Table 2a) . First weight measure was taken on 12 day 0 and, the last measure was obtained, the sacrifice day. were found. This result is comparable with the data observed in our study.
19
Very scarce scientific literature related with in vivo toxic effects of ENs is available. shown in figure 3.
22
As exposed in figure 4a , the lowest EN A concentration was detected in colon and 1 duodenum with 2.2±0.7 mg/kg and 2.9±0.6 mg/kg respectively, probably because of a no EN A was detected neither in kidneys, stomach nor ileum.
12
Regarding the intraintestinal liquids, the highest EN A data was observed in the jejunum 13 content with 9.6±1.1 mg/kg, whereas the lowest in the duodenal liquid with 1.3±0.2 mg/kg. 
LC-MS-LIT determination of ENs degradation products
18
The gastrointestinal content extracts were also injected in the LC-MS-LIT to identify confirmed the glucose presence in the structure of the newly formed compound.
15
To sum up, EN A intestinal degradation products and adducts are described for the first probably produced by gut microbial fermentation, were identified and characterized. 
